US20050287530A1 - TCL-1b gene and protein and related methods and compositions - Google Patents
TCL-1b gene and protein and related methods and compositions Download PDFInfo
- Publication number
- US20050287530A1 US20050287530A1 US10/678,790 US67879003A US2005287530A1 US 20050287530 A1 US20050287530 A1 US 20050287530A1 US 67879003 A US67879003 A US 67879003A US 2005287530 A1 US2005287530 A1 US 2005287530A1
- Authority
- US
- United States
- Prior art keywords
- sequence
- protein
- tng1
- seq
- tng2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Marine Sciences & Fisheries (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/678,790 US20050287530A1 (en) | 1999-03-15 | 2003-10-02 | TCL-1b gene and protein and related methods and compositions |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12471499P | 1999-03-15 | 1999-03-15 | |
US52632900A | 2000-03-15 | 2000-03-15 | |
US10/678,790 US20050287530A1 (en) | 1999-03-15 | 2003-10-02 | TCL-1b gene and protein and related methods and compositions |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US52632900A Continuation | 1999-03-15 | 2000-03-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
US20050287530A1 true US20050287530A1 (en) | 2005-12-29 |
Family
ID=22416426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/678,790 Abandoned US20050287530A1 (en) | 1999-03-15 | 2003-10-02 | TCL-1b gene and protein and related methods and compositions |
Country Status (5)
Country | Link |
---|---|
US (1) | US20050287530A1 (de) |
EP (1) | EP1165586A4 (de) |
JP (1) | JP2003519463A (de) |
CA (1) | CA2367906A1 (de) |
WO (1) | WO2000055169A1 (de) |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100004322A1 (en) * | 2006-09-19 | 2010-01-07 | The Ohio State University Research Foundation | TCL1 Expression in Chronic Lymphocytic Leukemia (CLL) Regulated by MIR-29 and MIR-181 |
US7943318B2 (en) | 2006-01-05 | 2011-05-17 | The Ohio State University Research Foundation | Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer |
US7985584B2 (en) | 2006-03-20 | 2011-07-26 | The Ohio State University Research Foundation | MicroRNA fingerprints during human megakaryocytopoiesis |
US8034560B2 (en) | 2007-01-31 | 2011-10-11 | The Ohio State University Research Foundation | MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of acute myeloid leukemia (AML) |
US8053186B2 (en) | 2007-06-15 | 2011-11-08 | The Ohio State University Research Foundation | Oncogenic ALL-1 fusion proteins for targeting Drosha-mediated microRNA processing |
US8084199B2 (en) | 2006-07-13 | 2011-12-27 | The Ohio State University Research Foundation | Method of diagnosing poor survival prognosis colon cancer using microRNA-21 |
US8148069B2 (en) | 2006-01-05 | 2012-04-03 | The Ohio State University | MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of solid cancers |
US8252538B2 (en) | 2006-11-01 | 2012-08-28 | The Ohio State University | MicroRNA expression signature for predicting survival and metastases in hepatocellular carcinoma |
US8367632B2 (en) | 2007-07-31 | 2013-02-05 | Ohio State University Research Foundation | Methods for reverting methylation by targeting methyltransferases |
US8389210B2 (en) | 2006-01-05 | 2013-03-05 | The Ohio State University Research Foundation | MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors |
US8465918B2 (en) | 2007-08-03 | 2013-06-18 | The Ohio State University Research Foundation | Ultraconserved regions encoding ncRNAs |
US8465917B2 (en) | 2007-06-08 | 2013-06-18 | The Ohio State University Research Foundation | Methods for determining heptocellular carcinoma subtype and detecting hepatic cancer stem cells |
US8466119B2 (en) | 2007-08-22 | 2013-06-18 | The Ohio State University Research Foundation | Methods and compositions for inducing deregulation of EPHA7 and ERK phosphorylation in human acute leukemias |
US8481505B2 (en) | 2005-09-12 | 2013-07-09 | The Ohio State University Research Foundation | Compositions and methods for the diagnosis and therapy of BCL2-associated cancers |
US8658370B2 (en) | 2005-08-01 | 2014-02-25 | The Ohio State University Research Foundation | MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer |
US8664192B2 (en) | 2011-03-07 | 2014-03-04 | The Ohio State University | Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer |
US8859202B2 (en) | 2012-01-20 | 2014-10-14 | The Ohio State University | Breast cancer biomarker signatures for invasiveness and prognosis |
US8911998B2 (en) | 2007-10-26 | 2014-12-16 | The Ohio State University | Methods for identifying fragile histidine triad (FHIT) interaction and uses thereof |
US8916533B2 (en) | 2009-11-23 | 2014-12-23 | The Ohio State University | Materials and methods useful for affecting tumor cell growth, migration and invasion |
US8946187B2 (en) | 2010-11-12 | 2015-02-03 | The Ohio State University | Materials and methods related to microRNA-21, mismatch repair, and colorectal cancer |
US9125923B2 (en) | 2008-06-11 | 2015-09-08 | The Ohio State University | Use of MiR-26 family as a predictive marker for hepatocellular carcinoma and responsiveness to therapy |
US9249468B2 (en) | 2011-10-14 | 2016-02-02 | The Ohio State University | Methods and materials related to ovarian cancer |
US9481885B2 (en) | 2011-12-13 | 2016-11-01 | Ohio State Innovation Foundation | Methods and compositions related to miR-21 and miR-29a, exosome inhibition, and cancer metastasis |
US10758619B2 (en) | 2010-11-15 | 2020-09-01 | The Ohio State University | Controlled release mucoadhesive systems |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4819321B2 (ja) | 2003-12-15 | 2011-11-24 | 独立行政法人科学技術振興機構 | Akt活性特異的抑制ポリペプチド |
JP2006242618A (ja) * | 2005-03-01 | 2006-09-14 | Univ Of Tokyo | 組織fish法によるテロメア量を指標とした癌の診断 |
US9290541B2 (en) | 2011-11-18 | 2016-03-22 | Board Of Regents, The University Of Texas System | TCL1 peptides for immunotherapy |
US11919937B2 (en) | 2018-01-09 | 2024-03-05 | Board Of Regents, The University Of Texas System | T cell receptors for immunotherapy |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4215051A (en) * | 1979-08-29 | 1980-07-29 | Standard Oil Company (Indiana) | Formation, purification and recovery of phthalic anhydride |
US4683202A (en) * | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4683195A (en) * | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4737462A (en) * | 1982-10-19 | 1988-04-12 | Cetus Corporation | Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β |
US4795699A (en) * | 1987-01-14 | 1989-01-03 | President And Fellows Of Harvard College | T7 DNA polymerase |
US4889818A (en) * | 1986-08-22 | 1989-12-26 | Cetus Corporation | Purified thermostable enzyme |
US4946778A (en) * | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
US4980286A (en) * | 1985-07-05 | 1990-12-25 | Whitehead Institute For Biomedical Research | In vivo introduction and expression of foreign genetic material in epithelial cells |
US5985598A (en) * | 1994-10-27 | 1999-11-16 | Thomas Jefferson University | TCL-1 gene and protein and related methods and compositions |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9307754D0 (en) * | 1993-04-15 | 1993-06-02 | Perry Robert E | Diagnostic probes and therapeutic products |
-
2000
- 2000-03-15 WO PCT/US2000/006612 patent/WO2000055169A1/en active Application Filing
- 2000-03-15 JP JP2000605597A patent/JP2003519463A/ja active Pending
- 2000-03-15 EP EP00914959A patent/EP1165586A4/de not_active Withdrawn
- 2000-03-15 CA CA002367906A patent/CA2367906A1/en not_active Abandoned
-
2003
- 2003-10-02 US US10/678,790 patent/US20050287530A1/en not_active Abandoned
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4215051A (en) * | 1979-08-29 | 1980-07-29 | Standard Oil Company (Indiana) | Formation, purification and recovery of phthalic anhydride |
US4737462A (en) * | 1982-10-19 | 1988-04-12 | Cetus Corporation | Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β |
US4683202A (en) * | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4683202B1 (de) * | 1985-03-28 | 1990-11-27 | Cetus Corp | |
US4980286A (en) * | 1985-07-05 | 1990-12-25 | Whitehead Institute For Biomedical Research | In vivo introduction and expression of foreign genetic material in epithelial cells |
US4683195A (en) * | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4683195B1 (de) * | 1986-01-30 | 1990-11-27 | Cetus Corp | |
US4889818A (en) * | 1986-08-22 | 1989-12-26 | Cetus Corporation | Purified thermostable enzyme |
US4795699A (en) * | 1987-01-14 | 1989-01-03 | President And Fellows Of Harvard College | T7 DNA polymerase |
US4946778A (en) * | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
US5985598A (en) * | 1994-10-27 | 1999-11-16 | Thomas Jefferson University | TCL-1 gene and protein and related methods and compositions |
Cited By (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8658370B2 (en) | 2005-08-01 | 2014-02-25 | The Ohio State University Research Foundation | MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer |
US8481505B2 (en) | 2005-09-12 | 2013-07-09 | The Ohio State University Research Foundation | Compositions and methods for the diagnosis and therapy of BCL2-associated cancers |
US7943318B2 (en) | 2006-01-05 | 2011-05-17 | The Ohio State University Research Foundation | Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer |
US8377637B2 (en) | 2006-01-05 | 2013-02-19 | The Ohio State University Research Foundation | MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer using miR-17-3P |
US8361710B2 (en) | 2006-01-05 | 2013-01-29 | The Ohio State University Research Foundation | MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer using miR-21 |
US8389210B2 (en) | 2006-01-05 | 2013-03-05 | The Ohio State University Research Foundation | MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors |
US8148069B2 (en) | 2006-01-05 | 2012-04-03 | The Ohio State University | MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of solid cancers |
US7985584B2 (en) | 2006-03-20 | 2011-07-26 | The Ohio State University Research Foundation | MicroRNA fingerprints during human megakaryocytopoiesis |
US8354224B2 (en) | 2006-03-20 | 2013-01-15 | The Ohio State University | MicroRNA fingerprints during human megakaryocytopoiesis |
US8084199B2 (en) | 2006-07-13 | 2011-12-27 | The Ohio State University Research Foundation | Method of diagnosing poor survival prognosis colon cancer using microRNA-21 |
US8071292B2 (en) | 2006-09-19 | 2011-12-06 | The Ohio State University Research Foundation | Leukemia diagnostic methods |
US20100004322A1 (en) * | 2006-09-19 | 2010-01-07 | The Ohio State University Research Foundation | TCL1 Expression in Chronic Lymphocytic Leukemia (CLL) Regulated by MIR-29 and MIR-181 |
US8252538B2 (en) | 2006-11-01 | 2012-08-28 | The Ohio State University | MicroRNA expression signature for predicting survival and metastases in hepatocellular carcinoma |
US8034560B2 (en) | 2007-01-31 | 2011-10-11 | The Ohio State University Research Foundation | MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of acute myeloid leukemia (AML) |
US8465917B2 (en) | 2007-06-08 | 2013-06-18 | The Ohio State University Research Foundation | Methods for determining heptocellular carcinoma subtype and detecting hepatic cancer stem cells |
US8053186B2 (en) | 2007-06-15 | 2011-11-08 | The Ohio State University Research Foundation | Oncogenic ALL-1 fusion proteins for targeting Drosha-mediated microRNA processing |
US8361722B2 (en) | 2007-06-15 | 2013-01-29 | The Ohio State University Research Foundation | Method for diagnosing acute lymphomic leukemia (ALL) using miR-221 |
US8349560B2 (en) | 2007-06-15 | 2013-01-08 | The Ohio State University Research | Method for diagnosing acute lymphomic leukemia (ALL) using miR-222 |
US8367632B2 (en) | 2007-07-31 | 2013-02-05 | Ohio State University Research Foundation | Methods for reverting methylation by targeting methyltransferases |
US8465918B2 (en) | 2007-08-03 | 2013-06-18 | The Ohio State University Research Foundation | Ultraconserved regions encoding ncRNAs |
US9085804B2 (en) | 2007-08-03 | 2015-07-21 | The Ohio State University Research Foundation | Ultraconserved regions encoding ncRNAs |
US8466119B2 (en) | 2007-08-22 | 2013-06-18 | The Ohio State University Research Foundation | Methods and compositions for inducing deregulation of EPHA7 and ERK phosphorylation in human acute leukemias |
US8911998B2 (en) | 2007-10-26 | 2014-12-16 | The Ohio State University | Methods for identifying fragile histidine triad (FHIT) interaction and uses thereof |
US9125923B2 (en) | 2008-06-11 | 2015-09-08 | The Ohio State University | Use of MiR-26 family as a predictive marker for hepatocellular carcinoma and responsiveness to therapy |
US8916533B2 (en) | 2009-11-23 | 2014-12-23 | The Ohio State University | Materials and methods useful for affecting tumor cell growth, migration and invasion |
US8946187B2 (en) | 2010-11-12 | 2015-02-03 | The Ohio State University | Materials and methods related to microRNA-21, mismatch repair, and colorectal cancer |
US10758619B2 (en) | 2010-11-15 | 2020-09-01 | The Ohio State University | Controlled release mucoadhesive systems |
US11679157B2 (en) | 2010-11-15 | 2023-06-20 | The Ohio State University | Controlled release mucoadhesive systems |
US8664192B2 (en) | 2011-03-07 | 2014-03-04 | The Ohio State University | Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer |
US9249468B2 (en) | 2011-10-14 | 2016-02-02 | The Ohio State University | Methods and materials related to ovarian cancer |
US9481885B2 (en) | 2011-12-13 | 2016-11-01 | Ohio State Innovation Foundation | Methods and compositions related to miR-21 and miR-29a, exosome inhibition, and cancer metastasis |
US8859202B2 (en) | 2012-01-20 | 2014-10-14 | The Ohio State University | Breast cancer biomarker signatures for invasiveness and prognosis |
US9434995B2 (en) | 2012-01-20 | 2016-09-06 | The Ohio State University | Breast cancer biomarker signatures for invasiveness and prognosis |
Also Published As
Publication number | Publication date |
---|---|
WO2000055169A1 (en) | 2000-09-21 |
EP1165586A1 (de) | 2002-01-02 |
EP1165586A4 (de) | 2003-05-28 |
JP2003519463A (ja) | 2003-06-24 |
CA2367906A1 (en) | 2000-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20050287530A1 (en) | TCL-1b gene and protein and related methods and compositions | |
US7749715B2 (en) | TCL-1 gene and protein and related methods and compositions | |
US7175995B1 (en) | TCL-1 protein and related methods | |
US6774217B1 (en) | FHIT proteins and nucleic acids and methods based thereon | |
US5928884A (en) | FHIT proteins and nucleic acids and methods based thereon | |
WO1995013387A1 (en) | Tie-2, a novel receptor tyrosine kinase | |
JP2010047588A (ja) | 新規膜貫通蛋白質をコードする遺伝子 | |
JPH10510422A (ja) | チロシンリン酸化タンパク質に結合する新規なタンパク質ドメイン | |
JP2001521372A (ja) | ヒトP2x4レセプタースプライス−変異体 | |
ES2322971T3 (es) | Proteina sr-p70 purificada. | |
AU7966498A (en) | Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activity | |
US6307035B1 (en) | BRCA1 associated polynucleotide (BAP-1) and uses therefor | |
US6458534B1 (en) | Gene associated with Nijmegen breakage syndrome, it's gene product and methods for their use | |
US6590089B1 (en) | RVP-1 variant differentially expressed in Crohn's disease | |
EP1364963A1 (de) | Neues, natürliches antibakterielles peptid, die für dieses peptid codierende nukleotidsequenz und dessen verwendung | |
JPH10201491A (ja) | タンパク質ホスファターゼ1結合タンパク質r5 | |
US5639651A (en) | Gap-related gene, human IQGAP1 | |
US6309821B1 (en) | DNA encoding a PAC10 human homolog | |
CA2319782A1 (en) | Retinoblastoma protein complexes and retinoblastoma interacting proteins | |
JP2002186492A (ja) | ヒトrce1 | |
JP2002504327A (ja) | セレベリン−2関連ポリペプチドおよび該ポリペプチドをコードするdna | |
US6673911B1 (en) | Human polyhomeotic 2 (hph2) acts as an oncogene | |
MXPA01013265A (es) | Proteina citoplasmica que liga calcio inducida por un trauma de cabeza. | |
JPH10127296A (ja) | Ext2遺伝子 | |
WO1993020201A1 (en) | GAP-ASSOCIATED PROTEIN p190 AND TRANSDUCTION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |